Junior Lanzol 30mg Tablet DT contains Lansoprazole, a proton pump inhibitor indicated for the treatment of acid-related gastrointestinal conditions in pediatric patients. Lansoprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion. Junior Lanzol 30mg Tablet DT is specifically formulated as a dispersible tablet to facilitate ease of administration in children who may have difficulty swallowing conventional tablets. It is primarily used for the management of gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease, including those associated with Helicobacter pylori infection when used in combination with appropriate antibiotics. The dispersible formulation allows rapid disintegration in water, ensuring prompt onset of action and improved patient compliance. Dosage and duration of therapy should be determined by a healthcare professional based on the severity of the condition and patient response. Common adverse effects may include headache, abdominal pain, nausea, and diarrhea; however, Lansoprazole is generally well tolerated. Caution is advised in patients with known hypersensitivity to proton pump inhibitors. Junior Lanzol 30mg Tablet DT should be stored in a cool, dry place away from direct sunlight and out of reach of children.